Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

BVS Bioventus Inc

10,13

0,00 (0,00%)

Dernière mise à jour : 21:24:12

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Part of Issuer sell to cover program

Date of Notice

01/13/2025

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

01/11/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Anthony D'Adamio, Attorney-in-Fact

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Bioventus (NASDAQ:BVS)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Plus de graphiques de la Bourse Bioventus

Bioventus (NASDAQ:BVS)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025

Plus de graphiques de la Bourse Bioventus

Actualités Bioventus Inc

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 21 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Vendredi 21 Février 2025 ( il y a 6 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 19 Février 2025 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 15 Janvier 2025 ( il y a 1 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mardi 14 Janvier 2025 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 13 Janvier 2025 ( il y a 1 mois) • Edgar (US Regulatory)

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mardi 7 Janvier 2025 ( il y a 2 mois) • GlobeNewswire Inc.

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
Jeudi 2 Janvier 2025 ( il y a 2 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 26 Décembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 26 Décembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lundi 23 Décembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Plus d'articles sur Bioventus Inc

Intesa Sanpaolo

Vontobel Financial Produ...

Societe Generale Effekten

Vontobel Financial Produ...

Leonteq Securities

Ubs Lux Fund Sol Bbg Eur...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales